Found: 69
Select item for more details and to access through your institution.
Occurrence of High Microsatellite-Instability/Mismatch Repair Deficiency in Nearly 2,000 Human Adenocarcinomas of the Gastrointestinal Tract, Pancreas, and Bile Ducts: A Study From a Large German Comprehensive Cancer Center.
- Published in:
- Frontiers in Oncology, 2021, v. 11, p. 1, doi. 10.3389/fonc.2021.569475
- By:
- Publication type:
- Article
Heme oxygenase-1 germ line GTn promoter polymorphism is an independent prognosticator of tumor recurrence and survival in pancreatic cancer.
- Published in:
- Journal of Surgical Oncology, 2011, v. 104, n. 3, p. 305, doi. 10.1002/jso.21926
- By:
- Publication type:
- Article
Prognostic impact of CXCR4 and CXCR7 expression in pancreatic adenocarcinoma.
- Published in:
- Journal of Surgical Oncology, 2011, v. 104, n. 2, p. 140, doi. 10.1002/jso.21957
- By:
- Publication type:
- Article
Parameters predicting postoperative pain and quality of life after hemorrhoidectomy: follow-up results from a prospective multicenter randomized trial.
- Published in:
- International Journal of Colorectal Disease, 2023, v. 38, n. 1, p. 1, doi. 10.1007/s00384-023-04557-9
- By:
- Publication type:
- Article
ASO Visual Abstract: Long-Term Postsurgical Outcomes of Neoadjuvant Chemoradiation (CROSS) Versus Chemotherapy (FLOT) for Multimodal Treatment of Adenocarcinoma of the Esophagus and the Esophagogastric Junction.
- Published in:
- 2023
- By:
- Publication type:
- Abstract
Long-Term Postsurgical Outcomes of Neoadjuvant Chemoradiation (CROSS) Versus Chemotherapy (FLOT) for Multimodal Treatment of Adenocarcinoma of the Esophagus and the Esophagogastric Junction.
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2023, v. 30, n. 12, p. 7422, doi. 10.1245/s10434-023-13643-9
- By:
- Publication type:
- Article
Long-Term Outcome After Histopathological Complete Response with and Without Nodal Metastases Following Multimodal Treatment of Esophageal Cancer.
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2022, v. 29, n. 7, p. 4419, doi. 10.1245/s10434-022-11700-3
- By:
- Publication type:
- Article
Predicting the HER2 status in oesophageal cancer from tissue microarrays using convolutional neural networks.
- Published in:
- British Journal of Cancer, 2023, v. 128, n. 7, p. 1369, doi. 10.1038/s41416-023-02143-y
- By:
- Publication type:
- Article
HER2/neu (ERBB2) expression and gene amplification correlates with better survival in esophageal adenocarcinoma.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Tumor budding assessed according to the criteria of the International Tumor Budding Consensus Conference determines prognosis in resected esophageal adenocarcinoma.
- Published in:
- Virchows Archiv: European Journal of Pathology, 2021, v. 478, n. 3, p. 393, doi. 10.1007/s00428-020-02897-3
- By:
- Publication type:
- Article
Sex-specific prognostic effect of CD66b-positive tumor-infiltrating neutrophils (TANs) in gastric and esophageal adenocarcinoma.
- Published in:
- Gastric Cancer, 2021, v. 24, n. 6, p. 1213, doi. 10.1007/s10120-021-01197-2
- By:
- Publication type:
- Article
Syndecan-1 expression is an independent favourable prognostic marker in oesophageal adenocarcinoma and represents a potential therapeutic target.
- Published in:
- Oncology Letters, 2023, v. 26, n. 2, p. 1, doi. 10.3892/ol.2023.13942
- By:
- Publication type:
- Article
Morphological, clinical and molecular characteristics in ARID1a‑deficient microsatellite‑stable oesophageal adenocarcinoma.
- Published in:
- Oncology Letters, 2023, v. 25, n. 6, p. N.PAG, doi. 10.3892/ol.2023.13840
- By:
- Publication type:
- Article
Claudin 18.2 expression in esophageal adenocarcinoma and its potential impact on future treatment strategies.
- Published in:
- Oncology Letters, 2020, v. 19, n. 6, p. 3665, doi. 10.3892/ol.2020.11520
- By:
- Publication type:
- Article
p53 overexpression is a prognosticator of poor outcome in esophageal cancer.
- Published in:
- Oncology Letters, 2019, v. 17, n. 4, p. 3826
- By:
- Publication type:
- Article
Integrin alpha-V is an important driver in pancreatic adenocarcinoma progression.
- Published in:
- Journal of Experimental & Clinical Cancer Research (17569966), 2021, v. 40, n. 1, p. 1, doi. 10.1186/s13046-021-01946-2
- By:
- Publication type:
- Article
Tumor cell integrin β4 and tumor stroma E-/P-selectin cooperatively regulate tumor growth in vivo.
- Published in:
- Journal of Hematology & Oncology, 2023, v. 16, n. 1, p. 1, doi. 10.1186/s13045-023-01413-9
- By:
- Publication type:
- Article
Dissecting the inflammatory tumor microenvironment of esophageal adenocarcinoma: mast cells and natural killer cells are favorable prognostic factors and associated with less extensive disease.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2023, v. 149, n. 10, p. 6917, doi. 10.1007/s00432-023-04650-0
- By:
- Publication type:
- Article
FGFR2-amplified tumor clones are markedly heterogeneously distributed in carcinomas of the upper gastrointestinal tract.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2023, v. 149, n. 8, p. 5289, doi. 10.1007/s00432-022-04460-w
- By:
- Publication type:
- Article
Fructose-1,6-bisphosphatase 1 (FBP1) is an independent biomarker associated with a favorable prognosis in esophageal adenocarcinoma.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2022, v. 148, n. 9, p. 2287, doi. 10.1007/s00432-022-04025-x
- By:
- Publication type:
- Article
GATA binding protein 6 (GATA6) is co-amplified with PIK3CA in patients with esophageal adenocarcinoma and is linked to neoadjuvant therapy.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2021, v. 147, n. 4, p. 1031, doi. 10.1007/s00432-020-03486-2
- By:
- Publication type:
- Article
Lymphocyte activation gene-3 (LAG3) mRNA and protein expression on tumour infiltrating lymphocytes (TILs) in oesophageal adenocarcinoma.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2020, v. 146, n. 9, p. 2319, doi. 10.1007/s00432-020-03295-7
- By:
- Publication type:
- Article
Aberrant expression of Sec61α in esophageal cancers.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2019, v. 145, n. 8, p. 2039, doi. 10.1007/s00432-019-02955-7
- By:
- Publication type:
- Article
Carcinoembryonic Antigen-Related Cell Adhesion Molecules (CEACAM) 1, 5 and 6 as Biomarkers in Pancreatic Cancer.
- Published in:
- PLoS ONE, 2014, v. 9, n. 11, p. 1, doi. 10.1371/journal.pone.0113023
- By:
- Publication type:
- Article
ALCAM (CD166) Expression and Serum Levels in Pancreatic Cancer.
- Published in:
- PLoS ONE, 2012, v. 7, n. 6, p. 1, doi. 10.1371/journal.pone.0039018
- By:
- Publication type:
- Article
Activated Leukocyte Cell Adhesion Molecule (CD166): An 'Inert' Cancer Stem Cell Marker for Non-Small Cell Lung Cancer?
- Published in:
- Stem Cells, 2014, v. 32, n. 6, p. 1429, doi. 10.1002/stem.1665
- By:
- Publication type:
- Article
CXCR7 expression in esophageal cancer.
- Published in:
- Journal of Translational Medicine, 2013, v. 11, n. 1, p. 1, doi. 10.1186/1479-5876-11-238
- By:
- Publication type:
- Article
CXCR7 expression in esophageal cancer.
- Published in:
- 2013
- By:
- Publication type:
- journal article
Mesothelin expression in esophageal adenocarcinoma and squamous cell carcinoma and its possible impact on future treatment strategies.
- Published in:
- Therapeutic Advances in Medical Oncology, 2020, v. 12, p. 1, doi. 10.1177/1758835920917571
- By:
- Publication type:
- Article
Study protocol of an open-label, single arm phase II trial investigating the efficacy, safety and quality of life of neoadjuvant chemotherapy with liposomal irinotecan combined with Oxaliplatin and 5-fluorouracil/Folinic acid followed by curative surgical resection in patients with hepatic Oligometastatic adenocarcinoma of the pancreas (HOLIPANC).
- Published in:
- 2021
- By:
- Publication type:
- journal article
Prognostic relevance of ubiquitin C-terminal hydrolase L1 (UCH-L1) mRNA and protein expression in breast cancer patients.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2013, v. 139, n. 10, p. 1745, doi. 10.1007/s00432-013-1496-z
- By:
- Publication type:
- Article
True single-port cholecystectomy with ICG cholangiography through a single 15-mm trocar using the new surgical platform "symphonX": first human case study with a commercially available device.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Integrin alpha V (ITGAV) expression in esophageal adenocarcinoma is associated with shortened overall-survival.
- Published in:
- Scientific Reports, 2020, v. 10, n. 1, p. N.PAG, doi. 10.1038/s41598-020-75085-7
- By:
- Publication type:
- Article
Is hyaluronan deposition in the stroma of pancreatic ductal adenocarcinoma of prognostic significance?
- Published in:
- PLoS ONE, 2017, v. 12, n. 6, p. 1, doi. 10.1371/journal.pone.0178703
- By:
- Publication type:
- Article
Resection Margin Clearance in Pancreatic Cancer After Implementation of the Leeds Pathology Protocol (LEEPP): Clinically Relevant or Just Academic?
- Published in:
- World Journal of Surgery, 2015, v. 39, n. 2, p. 493, doi. 10.1007/s00268-014-2808-4
- By:
- Publication type:
- Article
Multivisceral Resections in Pancreatic Cancer: Identification of Risk Factors.
- Published in:
- World Journal of Surgery, 2011, v. 35, n. 12, p. 2756, doi. 10.1007/s00268-011-1263-8
- By:
- Publication type:
- Article
High Surgical Morbidity Following Distal Pancreatectomy: Still an Unsolved Problem.
- Published in:
- World Journal of Surgery, 2011, v. 35, n. 5, p. 1110, doi. 10.1007/s00268-011-1022-x
- By:
- Publication type:
- Article
Sequential neoadjuvant chemoradiotherapy (CRT) followed by curative surgery vs. primary surgery alone for resectable, non-metastasized pancreatic adenocarcinoma: NEOPA- a randomized multicenter phase III study (NCT01900327, DRKS00003893).
- Published in:
- BMC Cancer, 2014, v. 14, n. 1, p. 1, doi. 10.1186/1471-2407-14-411
- By:
- Publication type:
- Article
Sequential neoadjuvant chemoradiotherapy (CRT) followed by curative surgery vs. primary surgery alone for resectable, non-metastasized pancreatic adenocarcinoma: NEOPA- a randomized multicenter phase III study (NCT01900327, DRKS00003893, ISRCTN82191749).
- Published in:
- BMC Cancer, 2014, v. 14, p. 1, doi. 10.1186/1471-2407-14-411
- By:
- Publication type:
- Article
Sequential neoadjuvant chemoradiotherapy (CRT) followed by curative surgery vs. primary surgery alone for resectable, non-metastasized pancreatic adenocarcinoma: NEOPA- a randomized multicenter phase III study (NCT01900327, DRKS00003893, ISRCTN82191749).
- Published in:
- 2014
- By:
- Publication type:
- journal article
Immune profile and immunosurveillance in treatment-naive and neoadjuvantly treated esophageal adenocarcinoma.
- Published in:
- Cancer Immunology, Immunotherapy, 2020, v. 69, n. 4, p. 523, doi. 10.1007/s00262-019-02475-w
- By:
- Publication type:
- Article
Indoleamine 2,3-Dioxygenase (IDO) Expression Is an Independent Prognostic Marker in Esophageal Adenocarcinoma.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Integrin beta1 (ITGB1) as a prognostic marker in esophageal adenocarcinoma.
- Published in:
- Scientific Reports, 2022, v. 12, n. 1, p. 1, doi. 10.1038/s41598-022-25071-y
- By:
- Publication type:
- Article
Failure of a Multi-Centric Clinical Trial Investigating Neoadjuvant Radio-Chemotherapy in Resectable Pancreatic Carcinoma (NEOPA-NCT01900327)—Which Lessons Are Learnt?
- Published in:
- Cancers, 2023, v. 15, n. 17, p. 4262, doi. 10.3390/cancers15174262
- By:
- Publication type:
- Article
Trophoblast Cell Surface Antigen 2 (TROP2) as a Predictive Bio-Marker for the Therapeutic Efficacy of Sacituzumab Govitecan in Adenocarcinoma of the Esophagus.
- Published in:
- Cancers, 2022, v. 14, n. 19, p. 4789, doi. 10.3390/cancers14194789
- By:
- Publication type:
- Article
Aldo-Keto Reductase 1C3 Mediates Chemotherapy Resistance in Esophageal Adenocarcinoma via ROS Detoxification.
- Published in:
- Cancers, 2021, v. 13, n. 10, p. 2403, doi. 10.3390/cancers13102403
- By:
- Publication type:
- Article
Does Circular Stapler Size in Surgical Management of Esophageal Cancer Affect Anastomotic Leak Rate? 4-Year Experience of a European High-Volume Center.
- Published in:
- Cancers, 2020, v. 12, n. 11, p. 3474, doi. 10.3390/cancers12113474
- By:
- Publication type:
- Article
Y Chromosome Loss Is a Frequent Event in Barrett's Adenocarcinoma and Associated with Poor Outcome.
- Published in:
- Cancers, 2020, v. 12, n. 7, p. 1743, doi. 10.3390/cancers12071743
- By:
- Publication type:
- Article
Dickkopf-2 (DKK2) as Context Dependent Factor in Patients with Esophageal Adenocarcinoma.
- Published in:
- Cancers, 2020, v. 12, n. 2, p. 451, doi. 10.3390/cancers12020451
- By:
- Publication type:
- Article
Glomangioma of the lung: a case report and review of the literature.
- Published in:
- 2014
- By:
- Publication type:
- Case Study